Category: Uncategorized

<h1>13th World Congress on Controversies in Neurology (CONy)</h1>

<p>13th World Congress on Controversies in Neurology (CONy)</p>

We are proud to announce that the 13th World Congress on Controversies in Neurology (CONy) will take place in Madrid, Spain on April 4-7, 2019.
It is difficult to keep pace with the enormous growth in clinical and basic data in neurology. Conferences are informative, but there is often only limited time for thorough and critical discussions. CONy provides a platform for international experts to discuss and compare experiences, thus closing the gap between the expansion of knowledge and its dissemination and use.
The core of the CONy Congress focus on unresolved issues debated by leading world experts. The Congress aims to provide the most recent data armoring the clinician with reliable, up-to-date scientific information, helping in everyday patient care.
We cordially invite you to join us in the beautiful city of Madrid!

We are proud to announce that the 13th World Congress on Controversies in Neurology (CONy) will take place in Madrid, Spain on April 4-7, 2019.
It is difficult to keep pace with the enormous growth in clinical and basic data in neurology. Conferences are informative, but there is often only limited time for thorough and critical discussions. CONy provides a platform for international experts to discuss and compare experiences, thus closing the gap between the expansion of knowledge and its dissemination and use.
The core of the CONy Congress focus on unresolved issues debated by leading world experts. The Congress aims to provide the most recent data armoring the clinician with reliable, up-to-date scientific information, helping in everyday patient care.
We cordially invite you to join us in the beautiful city of Madrid!

We are proud to announce that the 13th World Congress on Controversies in Neurology (CONy) will take place in Madrid, Spain on April 4-7, 2019.
It is difficult to keep pace with the enormous growth in clinical and basic data in neurology. Conferences are informative, but there is often only limited time for thorough and critical discussions. CONy provides a platform for international experts to discuss and compare experiences, thus closing the gap between the expansion of knowledge and its dissemination and use.
The core of the CONy Congress focus on unresolved issues debated by leading world experts. The Congress aims to provide the most recent data armoring the clinician with reliable, up-to-date scientific information, helping in everyday patient care.
We cordially invite you to join us in the beautiful city of Madrid!

<img src=”https://medicaleventsguide.com/wp-content/uploads/2017/07/medicalevents-logo.png” alt=”13th World Congress on Controversies in Neurology (CONy)” />
<a href=”https://medicaleventsguide.com/”> </a>
<a href=”https://www.plus91.in/”> </a>

<h1>35th Annual Conference, Obstetrics, Gynecology, Perinatal Medicine, Neonatology, and the Law</h1>

<p>35th Annual Conference, Obstetrics, Gynecology, Perinatal Medicine, Neonatology, and the Law</p>

To err is human, but so is the ability to anticipate and prevent or avoid medical error. When death or permanent harm occurs as a consequence of medical negligence, there is little, if any, likelihood that survivor or family will readily accept the refrain “to err is human”. Fortunately, not all who fall victim to medical error initiate legal action, but many do. The National Practitioner Database shows that between 2006-2016, for 102,659 sued physicians, there were 109,672 malpractice payments, and 60,460 Adverse Action Reports. The Physicians Insurers Association of America had, by 2012, paid out 81,000 claims, totaling nearly $25,000,000,000.
Despite the evolution of a “culture of patient safety” over almost two decades, death and harm due to medical negligence remain a serious problem. Indeed, estimates clearly indicate that medical negligence is the third cause of death in the US, after heart disease and cancer. It is of no comfort to know that medical negligence is universal.
While the causes of medical negligence are multi-factorial and complex, individual and systemic, there is a clear need for a fundamental change in the education of medical students and the training of residents. Moreover, required risk management credits for practicing physicians have largely been ineffective, and a new approach is long overdue.
These two multispecialty conferences bring into sharp focus new and established guidelines and standards of care, issues of competence, new advances, new judicial opinions, and ethics. The first conference concentrates on pregnancy, its management and the newborn, while the interdigitating and overlapping second conference takes up discussion along similar themes, but in multiple specialties.

To err is human, but so is the ability to anticipate and prevent or avoid medical error. When death or permanent harm occurs as a consequence of medical negligence, there is little, if any, likelihood that survivor or family will readily accept the refrain “to err is human”. Fortunately, not all who fall victim to medical error initiate legal action, but many do. The National Practitioner Database shows that between 2006-2016, for 102,659 sued physicians, there were 109,672 malpractice payments, and 60,460 Adverse Action Reports. The Physicians Insurers Association of America had, by 2012, paid out 81,000 claims, totaling nearly $25,000,000,000.
Despite the evolution of a “culture of patient safety” over almost two decades, death and harm due to medical negligence remain a serious problem. Indeed, estimates clearly indicate that medical negligence is the third cause of death in the US, after heart disease and cancer. It is of no comfort to know that medical negligence is universal.
While the causes of medical negligence are multi-factorial and complex, individual and systemic, there is a clear need for a fundamental change in the education of medical students and the training of residents. Moreover, required risk management credits for practicing physicians have largely been ineffective, and a new approach is long overdue.
These two multispecialty conferences bring into sharp focus new and established guidelines and standards of care, issues of competence, new advances, new judicial opinions, and ethics. The first conference concentrates on pregnancy, its management and the newborn, while the interdigitating and overlapping second conference takes up discussion along similar themes, but in multiple specialties.

<img src=”https://medicaleventsguide.com/wp-content/uploads/2017/07/medicalevents-logo.png” alt=”35th Annual Conference, Obstetrics, Gynecology, Perinatal Medicine, Neonatology, and the Law” />
<a href=”https://medicaleventsguide.com/”> </a>
<a href=”https://www.plus91.in/”> </a>

<h1>The Fertility 2019 Conference</h1>

<p>The Fertility 2019 Conference</p>

The theme for the joint annual conference is Technologies and controversies featuring an exciting, cutting edge programme of high profile, scientific international and UK speakers, with a wide range of concurrent sessions focussing on specialist areas in fertility and reproductive biology guaranteed to excite, stimulate and motivate!
The event will also feature over 200 scientific poster presentations, a large trade exhibition and a packed networking programme providing an excellent opportunity to learn, network and exchange ideas.

The theme for the joint annual conference is Technologies and controversies featuring an exciting, cutting edge programme of high profile, scientific international and UK speakers, with a wide range of concurrent sessions focussing on specialist areas in fertility and reproductive biology guaranteed to excite, stimulate and motivate!
The event will also feature over 200 scientific poster presentations, a large trade exhibition and a packed networking programme providing an excellent opportunity to learn, network and exchange ideas.

The theme for the joint annual conference is Technologies and controversies featuring an exciting, cutting edge programme of high profile, scientific international and UK speakers, with a wide range of concurrent sessions focussing on specialist areas in fertility and reproductive biology guaranteed to excite, stimulate and motivate!
The event will also feature over 200 scientific poster presentations, a large trade exhibition and a packed networking programme providing an excellent opportunity to learn, network and exchange ideas.

The theme for the joint annual conference is Technologies and controversies featuring an exciting, cutting edge programme of high profile, scientific international and UK speakers, with a wide range of concurrent sessions focussing on specialist areas in fertility and reproductive biology guaranteed to excite, stimulate and motivate!
The event will also feature over 200 scientific poster presentations, a large trade exhibition and a packed networking programme providing an excellent opportunity to learn, network and exchange ideas.

<img src=”https://medicaleventsguide.com/wp-content/uploads/2017/07/medicalevents-logo.png” alt=”The Fertility 2019 Conference” />
<a href=”https://medicaleventsguide.com/”> </a>
<a href=”https://www.plus91.in/”> </a>

<h1>Novel Biomarkers, TMB and Immuno-Oncology Summit</h1>

<p>Novel Biomarkers, TMB and Immuno-Oncology Summit</p>

Global Engage is pleased to announce the Novel Biomarkers, TMB and Immuno-Oncology Summit, to be held on January 31 – February 1 in London, UK.
The field of immuno-oncology offers a revolution in patient treatment and with an expected market value of $100 billion in 2023 it is set to become a vital weapon in the fight against cancer. Designed for experts in industry and academia working in this growing field, this conference will examine cutting edge research in several exciting and rapidly developing large molecule areas across 4 dedicated tracks. Talks will look to cover recent advances in antibody technology, including bispecific t cell engagers and monoclonal checkpoint inhibitors, new cancer biomarkers and the potential of the tumor mutational burden as a predictive tool for treatment efficacy, and recent developments in the fields of CAR T and TCR therapy. Exploring the early stage development of these exciting large molecule immunotherapies, these dedicated tracks will take you through the stages of discovery, engineering, optimization and translational research.
With over 35 individual presentations and 150 expected attendees, this interactive meeting will allow you to keep up to date with the cutting edge of research and provides the opportunity to make connections with industry experts, researchers, investors and businesses in your field.

Global Engage is pleased to announce the Novel Biomarkers, TMB and Immuno-Oncology Summit, to be held on January 31 – February 1 in London, UK.
The field of immuno-oncology offers a revolution in patient treatment and with an expected market value of $100 billion in 2023 it is set to become a vital weapon in the fight against cancer. Designed for experts in industry and academia working in this growing field, this conference will examine cutting edge research in several exciting and rapidly developing large molecule areas across 4 dedicated tracks. Talks will look to cover recent advances in antibody technology, including bispecific t cell engagers and monoclonal checkpoint inhibitors, new cancer biomarkers and the potential of the tumor mutational burden as a predictive tool for treatment efficacy, and recent developments in the fields of CAR T and TCR therapy. Exploring the early stage development of these exciting large molecule immunotherapies, these dedicated tracks will take you through the stages of discovery, engineering, optimization and translational research.
With over 35 individual presentations and 150 expected attendees, this interactive meeting will allow you to keep up to date with the cutting edge of research and provides the opportunity to make connections with industry experts, researchers, investors and businesses in your field.

<img src=”https://medicaleventsguide.com/wp-content/uploads/2017/07/medicalevents-logo.png” alt=”Novel Biomarkers, TMB and Immuno-Oncology Summit” />
<a href=”https://medicaleventsguide.com/”> </a>
<a href=”https://www.plus91.in/”> </a>

<h1>ASENT Annual Meeting</h1>

<p>ASENT Annual Meeting</p>

SAVE THE DATE : The ASENT Annual Meeting provides the latest in basic science and clinical development, and features sessions on emerging therapies in Parkinson’s Disease and Movement Disorders, Pain, Multiple Sclerosis, Epilepsy and Neurodegenerative Disorders. Technological breakthroughs featured include the use of deep brain stimulation, spinal cord stimulation, genomic-based drug discovery, the growing emphasis on new drug delivery systems.

SAVE THE DATE : The ASENT Annual Meeting provides the latest in basic science and clinical development, and features sessions on emerging therapies in Parkinson’s Disease and Movement Disorders, Pain, Multiple Sclerosis, Epilepsy and Neurodegenerative Disorders. Technological breakthroughs featured include the use of deep brain stimulation, spinal cord stimulation, genomic-based drug discovery, the growing emphasis on new drug delivery systems.

SAVE THE DATE : The ASENT Annual Meeting provides the latest in basic science and clinical development, and features sessions on emerging therapies in Parkinson’s Disease and Movement Disorders, Pain, Multiple Sclerosis, Epilepsy and Neurodegenerative Disorders. Technological breakthroughs featured include the use of deep brain stimulation, spinal cord stimulation, genomic-based drug discovery, the growing emphasis on new drug delivery systems.

SAVE THE DATE : The ASENT Annual Meeting provides the latest in basic science and clinical development, and features sessions on emerging therapies in Parkinson’s Disease and Movement Disorders, Pain, Multiple Sclerosis, Epilepsy and Neurodegenerative Disorders. Technological breakthroughs featured include the use of deep brain stimulation, spinal cord stimulation, genomic-based drug discovery, the growing emphasis on new drug delivery systems.

SAVE THE DATE : The ASENT Annual Meeting provides the latest in basic science and clinical development, and features sessions on emerging therapies in Parkinson’s Disease and Movement Disorders, Pain, Multiple Sclerosis, Epilepsy and Neurodegenerative Disorders. Technological breakthroughs featured include the use of deep brain stimulation, spinal cord stimulation, genomic-based drug discovery, the growing emphasis on new drug delivery systems.

<img src=”https://medicaleventsguide.com/wp-content/uploads/2017/07/medicalevents-logo.png” alt=”ASENT Annual Meeting” />
<a href=”https://medicaleventsguide.com/”> </a>
<a href=”https://www.plus91.in/”> </a>

<h1>Actrims Forum 2019</h1>

<p>Actrims Forum 2019</p>

Highlighting cutting edge studies that inform our understanding of the pathogenic mechanisms in MS, introduce novel measures to capture disease activity, and advance treatment options for affected individuals. This session will be comprised of platform presentations by Young Investigators selected from submitted abstracts. There will be eight 10 minute talks, each consisting of eight minute presentations and two minute Q&A.

Highlighting cutting edge studies that inform our understanding of the pathogenic mechanisms in MS, introduce novel measures to capture disease activity, and advance treatment options for affected individuals. This session will be comprised of platform presentations by Young Investigators selected from submitted abstracts. There will be eight 10 minute talks, each consisting of eight minute presentations and two minute Q&A.

Highlighting cutting edge studies that inform our understanding of the pathogenic mechanisms in MS, introduce novel measures to capture disease activity, and advance treatment options for affected individuals. This session will be comprised of platform presentations by Young Investigators selected from submitted abstracts. There will be eight 10 minute talks, each consisting of eight minute presentations and two minute Q&A.

Highlighting cutting edge studies that inform our understanding of the pathogenic mechanisms in MS, introduce novel measures to capture disease activity, and advance treatment options for affected individuals. This session will be comprised of platform presentations by Young Investigators selected from submitted abstracts. There will be eight 10 minute talks, each consisting of eight minute presentations and two minute Q&A.

Highlighting cutting edge studies that inform our understanding of the pathogenic mechanisms in MS, introduce novel measures to capture disease activity, and advance treatment options for affected individuals. This session will be comprised of platform presentations by Young Investigators selected from submitted abstracts. There will be eight 10 minute talks, each consisting of eight minute presentations and two minute Q&A.

Highlighting cutting edge studies that inform our understanding of the pathogenic mechanisms in MS, introduce novel measures to capture disease activity, and advance treatment options for affected individuals. This session will be comprised of platform presentations by Young Investigators selected from submitted abstracts. There will be eight 10 minute talks, each consisting of eight minute presentations and two minute Q&A.

<img src=”https://medicaleventsguide.com/wp-content/uploads/2017/07/medicalevents-logo.png” alt=”Actrims Forum 2019” />
<a href=”https://medicaleventsguide.com/”> </a>
<a href=”https://www.plus91.in/”> </a>

 

Workshop NeuroIntensiveMedicine ANIM 2019

Workshop NeuroIntensiveMedicine ANIM 2019

The treatment of neuromedical emergencies is relatively high in Germany, Austria and Switzerland. The greatest progress has been made in acute stroke; With 307 certified stroke units, the supply situation in Germany even stands out internationally. The interdisciplinary neurovascular centers and networks complement this nationwide structure and strengthen the cooperation between the partner subjects of neurology, neurosurgery and neuroradiology. But there are also new questions.
Do “interdisciplinary emergency medical outpatient clinics”, “integrated emergency centers” or independent central emergency departments in hospitals endanger or promote what has been achieved? Is preclinical decision-making sufficiently good to separate patients with non-acute threatening illnesses from those with time-critical conditions or to bring patients with a polytrauma, an acute coronary syndrome or a stroke on the individual optimal route in the hospital without loss of time? How do we solve the increasing problem of “self-presenting pedestrians”? These health policy issues will be addressed in the presidential symposium of ANIM 2019, as well as in several symposia.
Each year is dedicated to the ANIM – the A rbeitstagung N € I ntensiv Medizin – but above all our scientific advances and the further education of all occupational groups working in neurointensive medicine. As the President of the 36th Joint Annual Meeting of the German Society for Neuro-intensive and Emergency Medicine (DGNI) and the German Stroke Society (DSG), I would like to invite you to Berlin from 17 to 19 January 2019. Here again we would like to present and discuss comprehensive clinical studies. Other key topics will be the pre- and post-hospital phase of stroke treatment, but also subarachnoid haemorrhage and neuroinfectiology. Last but not least, we would also like to address concepts of training and promotion of young talent.

The treatment of neuromedical emergencies is relatively high in Germany, Austria and Switzerland. The greatest progress has been made in acute stroke; With 307 certified stroke units, the supply situation in Germany even stands out internationally. The interdisciplinary neurovascular centers and networks complement this nationwide structure and strengthen the cooperation between the partner subjects of neurology, neurosurgery and neuroradiology. But there are also new questions.
Do “interdisciplinary emergency medical outpatient clinics”, “integrated emergency centers” or independent central emergency departments in hospitals endanger or promote what has been achieved? Is preclinical decision-making sufficiently good to separate patients with non-acute threatening illnesses from those with time-critical conditions or to bring patients with a polytrauma, an acute coronary syndrome or a stroke on the individual optimal route in the hospital without loss of time? How do we solve the increasing problem of “self-presenting pedestrians”? These health policy issues will be addressed in the presidential symposium of ANIM 2019, as well as in several symposia.
Each year is dedicated to the ANIM – the A rbeitstagung N € I ntensiv Medizin – but above all our scientific advances and the further education of all occupational groups working in neurointensive medicine. As the President of the 36th Joint Annual Meeting of the German Society for Neuro-intensive and Emergency Medicine (DGNI) and the German Stroke Society (DSG), I would like to invite you to Berlin from 17 to 19 January 2019. Here again we would like to present and discuss comprehensive clinical studies. Other key topics will be the pre- and post-hospital phase of stroke treatment, but also subarachnoid haemorrhage and neuroinfectiology. Last but not least, we would also like to address concepts of training and promotion of young talent.

<h1>Silver Jubilee Conference of Paediatric Orthopaedic Society of India</h1>

<p>Silver Jubilee Conference of Paediatric Orthopaedic Society of India</p>

Dror Paley is the founder and Director of the Paley Institute in West Palm Beach, Florida, USA. Prior to that he was the founder Director of the Rubin Institute for Advanced Orthopedics, and the Director of the International Center for Limb Lengthening (ICLL) at Sinai Hospital of Baltimore from 2001-2009. He is internationally recognized for his expertise in limb lengthening and reconstruction. Dr. Paley trained under the guidance of Professor Ilizarov of Russia (Ilizarov method) and Professor di Bastiani of Italy (Orthofix method). In 1986, he introduced the Ilizarov method to the United States and Canada. He obtained subspecialty fellowship training over the course of three years in Pediatric Orthopedics, Hand Surgery, Trauma Surgery and Limb Lengthening and External Fixation Surgery. Dr. Paley has won several awards, including a Gubernatorial Citation for Outstanding Contributions in Orthopedic surgery in 1990 by the Governor of Maryland and the Pauwel’s Medal in Clinical Biomechanics in 1997 by the German-Speaking Countries Orthopedic Association. He has been awarded the best paper/poster award by SICOT, AAOS, POSNA and AORS. His book was also awarded the best-illustrated medical textbook in 2003. He was recently awarded Health Professional of the Year by the Chamber of Commerce of the Palm Beaches and was named Health Hero of the Year by the Palm Beach Medical Society. He has published over 130 articles in the peer-reviewed literature and has authored and edited 5 books and 40 book chapters. His book, Principles of Deformity Correction and Congenital Lower Limb Deformities, has set a new standard in the understanding and treatment of limb deformities.
Dror Paley is one of the star attractions of POSICON 2019. Besides sharing his vast experience in limb lengthening & limb reconstruction during the conference, he will conduct a not-to-be-missed special post-conference course on congenital limb deficiencies for the 1st time in the Indian sub-continent. Book your seats immediately for a once in lifetime opportunity.

<img src=”https://medicaleventsguide.com/wp-content/uploads/2017/07/medicalevents-logo.png” alt=”Silver Jubilee Conference of Paediatric Orthopaedic Society of India” />
<a href=”https://medicaleventsguide.com/”> </a>
<a href=”https://www.plus91.in/”> </a>

 

<h1>ICWEBCM 2019 : 21st International Conference on Wildlife Ecology, Biodiversity, Conservation and Management</h1>

<p>ICWEBCM 2019 : 21st International Conference on Wildlife Ecology, Biodiversity, Conservation and Management</p>

The International Research Conference is a federated organization dedicated to bringing together a significant number of diverse scholarly events for presentation within the conference program. Events will run over a span of time during the conference depending on the number and length of the presentations.
The ICWEBCM 2019 event aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Wildlife Ecology, Biodiversity, Conservation and Management. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Wildlife Ecology, Biodiversity, Conservation and Management.

The International Research Conference is a federated organization dedicated to bringing together a significant number of diverse scholarly events for presentation within the conference program. Events will run over a span of time during the conference depending on the number and length of the presentations.
The ICWEBCM 2019 event aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Wildlife Ecology, Biodiversity, Conservation and Management. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Wildlife Ecology, Biodiversity, Conservation and Management.

The International Research Conference is a federated organization dedicated to bringing together a significant number of diverse scholarly events for presentation within the conference program. Events will run over a span of time during the conference depending on the number and length of the presentations.
The ICWEBCM 2019 event aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Wildlife Ecology, Biodiversity, Conservation and Management. It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations, trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Wildlife Ecology, Biodiversity, Conservation and Management.

<img src=”https://medicaleventsguide.com/wp-content/uploads/2017/07/medicalevents-logo.png” alt=”ICWEBCM 2019 : 21st International Conference on Wildlife Ecology, Biodiversity, Conservation and Management” />
<a href=”https://medicaleventsguide.com/”> </a>
<a href=”https://www.plus91.in/”> </a>

<h1>23rd Edition of EuroSciCon Conference on Biotechnology & Bioengineering</h1>

<p>23rd Edition of EuroSciCon Conference on Biotechnology & Bioengineering<p>

The EuroSciCon is an eminent association that sorts out exceptionally pivotal meetings all through the globe. At present we are delivering 23rd Edition of EuroSciCon Conference on Biotechnology and Bioengineering which is going to be held in Amsterdam, Netherlands from March 4-6, 2019.
We are cheerfully welcoming for all Biotechnologists, Professors, Researchers, analysts, Business Giants, CEOs, COOs, Directors, Vice Presidents, Co-administrators, Managing Directors, Industry Safety Officers, Environmental and Plant Scientists, Post Doctorate Fellows, Vendors of Consumer Products/Managers, Bio-Engineers, Pharmaceutical Scientists, Students from the Biotechnology and its related locales, so focuses to share novel procedures related to biotechnology and examining the troubles concerning splendor in research and movements, EuroSciCon is the longest running self-governing life science events associated with a pervasively academic client base. Our multi-capable approach makes a stand-out the undertaking that can’t be found with an ace society or mechanically.

The EuroSciCon is an eminent association that sorts out exceptionally pivotal meetings all through the globe. At present we are delivering 23rd Edition of EuroSciCon Conference on Biotechnology and Bioengineering which is going to be held in Amsterdam, Netherlands from March 4-6, 2019.
We are cheerfully welcoming for all Biotechnologists, Professors, Researchers, analysts, Business Giants, CEOs, COOs, Directors, Vice Presidents, Co-administrators, Managing Directors, Industry Safety Officers, Environmental and Plant Scientists, Post Doctorate Fellows, Vendors of Consumer Products/Managers, Bio-Engineers, Pharmaceutical Scientists, Students from the Biotechnology and its related locales, so focuses to share novel procedures related to biotechnology and examining the troubles concerning splendor in research and movements, EuroSciCon is the longest running self-governing life science events associated with a pervasively academic client base. Our multi-capable approach makes a stand-out the undertaking that can’t be found with an ace society or mechanically.

The EuroSciCon is an eminent association that sorts out exceptionally pivotal meetings all through the globe. At present we are delivering 23rd Edition of EuroSciCon Conference on Biotechnology and Bioengineering which is going to be held in Amsterdam, Netherlands from March 4-6, 2019.
We are cheerfully welcoming for all Biotechnologists, Professors, Researchers, analysts, Business Giants, CEOs, COOs, Directors, Vice Presidents, Co-administrators, Managing Directors, Industry Safety Officers, Environmental and Plant Scientists, Post Doctorate Fellows, Vendors of Consumer Products/Managers, Bio-Engineers, Pharmaceutical Scientists, Students from the Biotechnology and its related locales, so focuses to share novel procedures related to biotechnology and examining the troubles concerning splendor in research and movements, EuroSciCon is the longest running self-governing life science events associated with a pervasively academic client base. Our multi-capable approach makes a stand-out the undertaking that can’t be found with an ace society or mechanically.

<img src=”https://medicaleventsguide.com/wp-content/uploads/2017/07/medicalevents-logo.png” alt=”23rd Edition of EuroSciCon Conference on Biotechnology & Bioengineering” />
<a href=”https://medicaleventsguide.com/”> </a>
<a href=”https://www.plus91.in/”> </a>